Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 6
2005 4
2006 6
2007 6
2008 6
2009 7
2010 11
2011 10
2012 15
2013 11
2014 15
2015 15
2016 16
2017 15
2018 11
2019 17
2020 18
2021 33
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

190 results
Results by year
Filters applied: . Clear all
Page 1
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, Jäger U, Jaglowski S, Andreadis C, Westin JR, Fleury I, Bachanova V, Foley SR, Ho PJ, Mielke S, Magenau JM, Holte H, Pantano S, Pacaud LB, Awasthi R, Chu J, Anak Ö, Salles G, Maziarz RT; JULIET Investigators. Schuster SJ, et al. N Engl J Med. 2019 Jan 3;380(1):45-56. doi: 10.1056/NEJMoa1804980. Epub 2018 Dec 1. N Engl J Med. 2019. PMID: 30501490 Clinical Trial.
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study.
Attal M, Richardson PG, Rajkumar SV, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Macé S, Corzo KP, Campana F, Le-Guennec S, Dubin F, Anderson KC; ICARIA-MM study group. Attal M, et al. Lancet. 2019 Dec 7;394(10214):2096-2107. doi: 10.1016/S0140-6736(19)32556-5. Epub 2019 Nov 14. Lancet. 2019. PMID: 31735560 Clinical Trial.
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial.
Kumar SK, Harrison SJ, Cavo M, de la Rubia J, Popat R, Gasparetto C, Hungria V, Salwender H, Suzuki K, Kim I, Punnoose EA, Hong WJ, Freise KJ, Yang X, Sood A, Jalaluddin M, Ross JA, Ward JE, Maciag PC, Moreau P. Kumar SK, et al. Among authors: harrison sj. Lancet Oncol. 2020 Dec;21(12):1630-1642. doi: 10.1016/S1470-2045(20)30525-8. Epub 2020 Oct 29. Lancet Oncol. 2020. PMID: 33129376 Clinical Trial.
Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis.
Dimopoulos MA, Leleu X, Moreau P, Richardson PG, Liberati AM, Harrison SJ, Miles Prince H, Ocio EM, Assadourian S, Campana F, Malinge L, Sémiond D, van de Velde H, Yong K. Dimopoulos MA, et al. Among authors: harrison sj. Leukemia. 2021 Feb;35(2):562-572. doi: 10.1038/s41375-020-0868-z. Epub 2020 May 23. Leukemia. 2021. PMID: 32444867 Free PMC article. Clinical Trial.
Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial.
Fisher H, Oluboyede Y, Chadwick T, Abdel-Fattah M, Brennand C, Fader M, Harrison S, Hilton P, Larcombe J, Little P, McClurg D, McColl E, N'Dow J, Ternent L, Thiruchelvam N, Timoney A, Vale L, Walton K, von Wilamowitz-Moellendorff A, Wilkinson J, Wood R, Pickard R. Fisher H, et al. Among authors: harrison s. Lancet Infect Dis. 2018 Sep;18(9):957-968. doi: 10.1016/S1473-3099(18)30279-2. Epub 2018 Jun 28. Lancet Infect Dis. 2018. PMID: 30037647 Free PMC article. Clinical Trial.
Multiple myeloma of the spine.
Lasocki A, Gaillard F, Harrison SJ. Lasocki A, et al. Among authors: harrison sj. Neuroradiol J. 2017 Jun;30(3):259-268. doi: 10.1177/1971400917699426. Epub 2017 Apr 20. Neuroradiol J. 2017. PMID: 28423980 Free PMC article. Review.
Levofloxacin prophylaxis in patients with myeloma.
Teh BW, Harrison SJ, Worth LJ, Thursky KA, Slavin MA. Teh BW, et al. Among authors: harrison sj. Lancet Oncol. 2020 Feb;21(2):e67. doi: 10.1016/S1470-2045(19)30824-1. Lancet Oncol. 2020. PMID: 32007198 No abstract available.
Clinical studies of histone deacetylase inhibitors.
Prince HM, Bishton MJ, Harrison SJ. Prince HM, et al. Among authors: harrison sj. Clin Cancer Res. 2009 Jun 15;15(12):3958-69. doi: 10.1158/1078-0432.CCR-08-2785. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509172 Free article. Review.
CAR-T cell therapy: practical guide to routine laboratory monitoring.
Selim AG, Minson A, Blombery P, Dickinson M, Harrison SJ, Anderson MA. Selim AG, et al. Among authors: harrison sj. Pathology. 2021 Apr;53(3):408-415. doi: 10.1016/j.pathol.2021.02.002. Epub 2021 Mar 5. Pathology. 2021. PMID: 33685719 Review.
Paving the way to precision medicine in multiple myeloma.
Inam S, Ross JA, Touzeau C, Moreau P, Kumar SK, Harrison SJ. Inam S, et al. Among authors: harrison sj. Expert Rev Hematol. 2021 Apr;14(4):323-327. doi: 10.1080/17474086.2021.1905515. Epub 2021 Apr 12. Expert Rev Hematol. 2021. PMID: 33729865 No abstract available.
190 results